Compare Snap On Incorporated (SNA) vs TG Therapeutics Inc (TGTX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Snap On Incorporated vs TG Therapeutics Inc — how do they compare? Snap On Incorporated trades at $402.3 (market cap $21.06B), while TG Therapeutics Inc trades at $54 (market cap $8.26B). The key difference: Snap On Incorporated is far larger — about 2.5× TG Therapeutics Inc's market cap, and Snap On Incorporated pays a 2.4% dividend while TG Therapeutics Inc pays none. Which is the better fit depends on your goals.
| SNA | TGTX | |
|---|---|---|
Market Cap | $21.06B | $8.26B |
Sector | Technology | Health |
52-Week High | $414.97 | $59.06 |
52-Week Low | $317.79 | $26.39 |
Enterprise Value | $20.58B | $8.50B |
Dividend Yield | 2.4% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Snap On Incorporated
Snap-on Incorporated is a leading global innovator, manufacturer, and marketer of tools, equipment, diagnostics, repair information, and systems solutions for professional users. Its products are widely used in vehicle service and repair, as well as in other demanding industrial environments. The company is best known for its premium tool brand, often sold through a network of franchised mobile stores, and is a primary supplier to technicians in the transportation industry.
Read more on SNA →About TG Therapeutics Inc
TG Therapeutics is a fully integrated biopharmaceutical company focused on the acquisition, development, and commercialization of novel treatments for B-cell mediated diseases. Its cornerstone product, BRIUMVI (ublituximab-xiiy), is a glycoengineered monoclonal antibody approved for relapsing forms of multiple sclerosis. The company is currently executing a 'pipeline-in-a-product' strategy, expanding BRIUMVI into new delivery methods and indications while advancing a broader portfolio of autoimmune and oncology candidates.
Read more on TGTX →
